Thiotepa Injection, Powder, Lyophilized, For Solution
Product Images NDC 72205-046

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Thiotepa (NDC 72205-046). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Strctre (Thiotapa Structure)

Strctre (Thiotapa Structure)
Chemical structure of Thiotepa, showing a phosphorothioate core with three aziridine rings attached to nitrogen atoms, consistent with the active ingredient Thiotepa.*
FDA Label Image

Thiotepa-for-injtn-100mg-carton-label (Thiotepa For Injtn 100mg Carton Label)

Thiotepa-for-injtn-100mg-carton-label (Thiotepa For Injtn 100mg Carton Label)
Packaging label for Thiotepa for Injection, USP 100 mg/vial, a lyophilized powder for solution by Novadoz Pharmaceuticals LLC. The label states it is for intravenous, intracavitary, or intravesical use, single dose vial, sterile, and cautions it is a cytotoxic agent. Storage instructions, reconstitution details, manufacturer (MSN Laboratories Pvt Ltd, India), distributor information, barcode, and lot details are also included.*
FDA Label Image

Thiotepa-for-injtn-100mg-vial-label (Thiotepa For Injtn 100mg Vial Label)

Thiotepa-for-injtn-100mg-vial-label (Thiotepa For Injtn 100mg Vial Label)
Thiotepa 100 mg/vial injection, powder, lyophilized for solution, for intravenous, intracavitary, or intravesical use. Single-dose vial labeled by Novadoz Pharmaceuticals LLC. The label shows NDC 72205-046-01, handling cautions as a cytotoxic agent, and placeholders for lot and expiration dates.*
FDA Label Image

Thiotepa-for-injtn-15mg-carton-label (Thiotepa For Injtn 15mg Carton Label)

Thiotepa-for-injtn-15mg-carton-label (Thiotepa For Injtn 15mg Carton Label)
Packaging label for Thiotepa for Injection, USP 15 mg per vial by Novadoz Pharmaceuticals LLC. The label indicates the drug is for intravenous, intracavitary, or intravesical use, supplied as a single-dose sterile vial. It includes storage instructions, manufacturer and distributor details, and caution for cytotoxicity. The NDC code 72205-045-01 is visible along with barcode and batch coding areas.*
FDA Label Image

Thiotepa-for-injtn-15mg-vial-label (Thiotepa For Injtn 15mg Vial Label)

Thiotepa-for-injtn-15mg-vial-label (Thiotepa For Injtn 15mg Vial Label)
Thiotepa 15 mg/vial injection powder label for solution by Novadoz Pharmaceuticals LLC. The label indicates intravenous, intracavitary, intravesical use with a single-dose vial. Includes lot number, expiration date, barcode, and storage information with a caution for cytotoxic agents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.